Lassnig Caroline, Sanchez Carlos M, Egerbacher Monika, Walter Ingrid, Majer Susanne, Kolbe Thomas, Pallares Pilar, Enjuanes Luis, Müller Mathias
Ludwig Boltzmann Institute for Immunogenetic, Cytogenetic, and Molecular Genetic Research, 1210 Vienna, Austria.
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8275-80. doi: 10.1073/pnas.0408589102. Epub 2005 May 26.
Human coronavirus (HCoV) 229E is a group 1 coronavirus and is specific to humans. So far, no animal model is available to study the pathogenesis of infection by HCoV-229E. We show here that the expression of aminopeptidase N (APN, also termed CD13), the receptor for HCoV-229E, is required but not sufficient to confer susceptibility in vivo. HCoV-229E infection was facilitated by crossing APN transgenic mice into signal transducers and activators of transcription (Stat) 1 null mice and by adaptation of HCoV-229E to grow in primary APN transgenic, Stat1 null fibroblasts. Double transgenic mice allow the study of human coronavirus group 1 infections in an animal model, in particular, viral tropism, replication, recombination, and spread in an immunocompromised situation. Furthermore, these mice provide an important tool for the evaluation of biosafety and efficacy of coronavirus-based vectors.
人冠状病毒(HCoV)229E属于1型冠状病毒,是人类特有的。到目前为止,尚无用于研究HCoV - 229E感染发病机制的动物模型。我们在此表明,HCoV - 229E的受体氨肽酶N(APN,也称为CD13)的表达是体内产生易感性所必需的,但并不充分。将APN转基因小鼠与信号转导及转录激活因子(Stat)1基因敲除小鼠杂交,以及使HCoV - 229E适应在原代APN转基因、Stat1基因敲除成纤维细胞中生长,均可促进HCoV - 229E感染。双转基因小鼠可用于在动物模型中研究1型人冠状病毒感染,特别是病毒嗜性、复制、重组以及在免疫受损情况下的传播。此外,这些小鼠为评估基于冠状病毒的载体的生物安全性和有效性提供了重要工具。